SCHEMBL21452862

SCHEMBL21452862

Cc1nc(-c2ccc(C(F)(F)F)c(F)c2)cc(N2CCCC(F)C2)n1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.44
▸ RPS6KB1 P23443 5/20 0.42
▸ AKT1 P31749 5/20 0.42
▸ CYP11B2 P19099 4/20 0.41
▸ CYP11B1 P15538 2/20 0.41
▸ PDE2A O00408 1/20 0.36
▸ GRM2 Q14416 2/20 0.36
▸ MAP3K12 Q12852 2/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ SYK P43405 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ ITGB2 P05107 1/20 0.35
▸ ICAM1 P05362 1/20 0.35
▸ ITGAL P20701 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21453034 0.80 KMT2A (0.47) KMT2AMAP3K12CHRM3PDE4APDE4B
SCHEMBL21452934 0.80 KMT2A (0.42) KMT2AGRM2MAP3K12CHRM3PDE4A
SCHEMBL21453057 0.77 RPS6KB1 (0.42) RPS6KB1AKT1CYP11B2CYP11B1PDE2A
SCHEMBL21452908 0.76 ITGB2 (0.48) RPS6KB1ITGB2ICAM1ITGAL
SCHEMBL21452909 0.76 ITGB2 (0.48) RPS6KB1ITGB2ICAM1ITGAL
SCHEMBL21452864 0.72 KMO (0.47) ITGB2ICAM1ITGAL
SCHEMBL21452772 0.71 KIF11 (0.38) KMT2ACYP11B2CYP11B1PDE2A
SCHEMBL21434135 0.70 KMT2A (0.53) KMT2ACYP11B2CYP11B1PDE2AGRM2
SCHEMBL3878855 0.68 GALR2 (0.48) —
SCHEMBL21452865 0.67 NPC1 (0.57) RPS6KB1AKT1CYP11B2CYP11B1ITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback